ESR1 and breast cancer: Cytoskeleton proteins involved in organelle biogenesis, mitosis, perinuclear development, and telomere aberrations need to be analyzed and differences between proteins expressed by ERα(+) and ERα(−) need to be identified in order to specifically target ERα(−) breast cancer.